K. Shimoda, H. Katsuragi / Tetrahedron: Asymmetry 21 (2010) 2060–2065
2063
13
using molecular biological techniques is currently under investiga-
tion to understand the molecular basis of its properties.
H-6); C NMR (100 MHz, CD3OD): d 62.5 (C-60), 65.9 (C-7), 72.5
(C-40), 76.2 (C-20), 79.0 (C-30, C-50), 104.5 (C-10), 118.0 (C-3), 124.1
(C-5), 124.5 (C-1), 130.9 (C-4), 131.0 (C-6), 158.2 (C-2).
2-Hydroxymethylphenyl b- -glucoside 2: HRFABMS: m/z 309.1164
D
[M+Na]+ (calcd for C13H18O7Na: 309.1162); 1H NMR (400 MHz,
CD3OD): d 3.28–3.51 (4H, m, H-20, 30, 40, 50), 3.69 (1H, dd, J = 12.2,
5.1 Hz, H-6a0), 3.87 (1H, dd, J = 12.0, 1.6 Hz, H-6b0), 4.56 (1H, d,
J = 7.2 Hz, H-10), 4.77 (1H, d, J = 12.0 Hz, H-7a), 4.86 (1H, d,
J = 12.0 Hz, H-7b), 7.00 (1H, td, J = 7.2, 2.0 Hz, H-5), 7.20 (1H, dd,
J = 7.2, 2.0 Hz, H-3), 7.25 (1H, td, J = 7.2, 2.0 Hz, H-4), 7.32 (1H, dd,
4. Experimental section
4.1. General
Chemicals such as o-, m-, and p-hydroxybenzylalcohol, (R)- and
(S)-1-phenylethanol, and (R)- and (S)-1-phenylbutanol were pur-
chased from Sigma–Aldrich Co. The suspension cells of C. roseus
were cultured in 500 mL conical flasks containing 300 mL of Schenk
and Hildebrand (SH) medium supplemented with 3% sucrose and
10 mM 2,4-D under illumination (4000 lux).14 HPLC analyses were
carried out with Puresil C18 column (Waters) using MeOH/H2O
(1:3, v/v) as a solvent (detect, UV280; flow rate, 1 mL minꢀ1). GLC
analyses were performed with FID and a capillary column of Rt-
bDEX (0.25 mm ꢁ 30 m) using N2 as a carrier gas (injector, 180 °C;
detector, 180 °C; make up, 50 mL minꢀ1). Optical rotation data were
obtained on a Jasco DIP-360 using a 4 mL cuvette. 1H and 13C NMR,
H–H COSY, C–H COSY, and HMBC spectra were measured on a Varian
XL-400 spectrometer. HRFABMS spectra were taken on a JEOL MSta-
tion JMS-700 spectrometer.
13
J = 7.2, 2.0 Hz, H-6); C NMR (100 MHz, CD3OD): d 63.5 (C-60),
68.5 (C-7), 72.4 (C-40), 76.0 (C-20), 78.0, 78.7 (C-30, C-50), 104.1 (C-
10), 117.0 (C-3), 121.4 (C-5), 125.8 (C-1), 130.9 (C-4), 131.9 (C-6),
157.3 (C-2).
3-Hydroxybenzyl b- -glucoside 3: HRFABMS: m/z 309.1161
D
[M+Na]+ (calcd for C13H18O7Na: 309.1162); 1H NMR (400 MHz,
CD3OD): d 3.19–3.31 (4H, m, H-20, 30, 40, 50), 3.64 (1H, dd, J = 11.8,
5.1 Hz, H-6a0), 3.85 (1H, dd, J = 11.8, 2.0 Hz, H-6b0), 4.30 (1H, d,
J = 7.7 Hz, H-10), 4.55 (1H, d, J = 11.5 Hz, H-7a), 4.82 (1H, d,
J = 11.5 Hz, H-7b), 6.65 (1H, m, H-6), 6.81 (1H, m, H-2), 6.82 (1H,
dd, J = 8.2, 1.4 Hz, H-4), 7.08 (1H, t, J = 8.2 Hz, H-5); 13C NMR
(100 MHz, CD3OD): d 63.5 (C-60), 72.5 (C-40, C-7), 76.1 (C-20),
78.7, 78.9 (C-30, C-50), 103.9 (C-10), 116.7 (C-6), 117.0 (C-2), 121.0
(C-4), 131.2 (C-5), 141.5 (C-1), 159.5 (C-3).
4.2. Substrates
3-Hydroxymethylphenyl b- -glucoside 4: HRFABMS: m/z 309.1162
D
[M+Na]+ (calcd for C13H18O7Na: 309.1162); 1H NMR (400 MHz,
CD3OD): d 3.33–3.41 (4H, m, H-20, 30, 40, 50), 3.65 (1H, dd, J = 11.2,
5.1 Hz, H-6a0), 3.86 (1H, dd, J = 12.0, 2.0 Hz, H-6b0), 4.53 (2H, m, H-
7), 4.86 (1H, d, J = 7.6 Hz, H-10), 6.95–6.97 (2H, m, H-4, 6), 7.06 (1H,
t, J = 2.0 Hz, H-2), 7.20 (1H, t, J = 7.8 Hz, H-5); 13C NMR (100 MHz,
CD3OD): d 63.4 (C-60), 65.5 (C-7), 72.2 (C-40), 75.7 (C-20), 78.9 (C-30,
C-50), 103.2 (C-10), 117.0 (C-2), 117.6 (C-4), 122.7 (C-6), 131.2 (C-
5), 145.1 (C-1), 159.9 (C-3).
Substrates such as p-nitrophenyl b-
-galactoside 8, p-nitrophenyl b- -xyloside 9, and p-nitrophenyl
-arabinoside 10 were purchased from Sigma–Aldrich Co.
2-Hydroxybenzyl b- -glucoside 1, 2-hydroxymethylphenyl b-
glucoside 2, 3-hydroxybenzyl b- -glucoside 3, 3-hydroxymethyl-
phenyl b- -glucoside 4, 4-hydroxybenzyl b- -glucoside 5, and
4-hydroxymethylphenyl b- -glucoside 6 were prepared by almond
b- -glucosidase-catalyzed reverse-hydrolysis according to the pre-
viously reported procedures.2 A typical synthetic method using
almond b- -glucosidase is as follows. To the mixture (20 mL) of ace-
tonitrile and water (9:1 v/v) including 5 mmol of -glucose and
700 U of almond b- -glucosidase were added 1.5 mmol of the corre-
D-glucoside 7, p-nitrophenyl
b-D
D
a-L
D
D-
D
D
D
D
D
4-Hydroxybenzyl b- -glucoside 5: HRFABMS: m/z 309.1169
D
[M+Na]+ (calcd for C13H18O7Na: 309.1162); 1H NMR (400 MHz,
CD3OD): d 3.16–3.30 (4H, m, H-20, 30, 40, 50), 3.85 (1H, dd, J = 12.0,
2.0 Hz, H-6a0), 3.62 (1H, dd, J = 12.0, 5.5 Hz, H-6b0), 4.28 (1H, d,
J = 7.6 Hz, H-10), 4.51 (1H, d, J = 11.2 Hz, H-7a), 4.77 (1H, d,
J = 11.2 Hz, H-7b), 6.70 (2H, d, J = 8.6 Hz, H-2, 6), 7.19 (2H, d,
D
D
D
sponding aglycone alcohols. The reaction mixture containing an
aglycone alcohol was individually incubated for 48 h at 40 °C. Con-
centration of the reaction mixture by evaporation under reduced
pressure followed by purification using column chromatography
13
J = 8.6 Hz, H-3, 5); C NMR (100 MHz, CD3OD): d 63.5 (C-60), 72.5
(C-40, C-7), 75.9 (C-20), 78.8 (C-30, C-50), 103.7 (C-10), 116.8 (C-3,
C-5), 120.2 (C-1), 132.0 (C-2, C-6), 159.0 (C-4).
on silica gel afforded b-D-glucoside. The yields of 1–6 were 9%, 6%,
5%, 3%, 5%, and 3%, respectively.
4-Hydroxymethylphenyl b- -glucoside 6: HRFABMS: m/z 309.1160
D
[M+Na]+ (calcd for C13H18O7Na: 309.1162); 1H NMR (400 MHz,
CD3OD): d 3.35–3.41 (4H, m, H-20, 30, 40, 50), 3.65 (1H, dd, J = 12.0,
4.2 Hz, H-6a0), 3.85 (1H, dd, J = 12.0, 1.8 Hz, H-6b0), 4.51 (2H, m, H-
7), 4.70 (1H, d, J = 7.3 Hz, H-10), 7.03 (2H, d, J = 8.8 Hz, H-2, 6), 7.23
(2H, d, J = 8.8 Hz, H-3, 5); 13C NMR (100 MHz, CD3OD): d 63.3 (C-
60), 65.5 (C-7), 72.2 (C-40), 75.5 (C-20), 78.8, 78.9 (C-30, C-50), 103.2
(C-10), 118.2 (C-3, C-5), 120.2 (C-1), 130.9 (C-2, C-6), 159.2 (C-4).
In the case of preparation of substrates composed of a 1:1 mix-
ture of (RS)-diastereomers, that is, (RS)-1-phenylethyl b-
side 11 or (RS)-1-phenylbutyl b- -glucoside 12, each 0.05 mmol
of (R)- and (S)-1-phenylalkyl b- -glucosides, which had been indi-
vidually synthesized from enantiomerically pure alcohols by al-
mond b- -glucosidase-catalyzed reverse-hydrolysis under similar
D-gluco-
D
D
D
conditions to the standard reaction system, except that the scale
was fivefold enlarged (yields of 11a, 11b, 12a, and 12b were 3%,
5%, 2%, and 4%), and were combined to be a substrate. The R/S ratio
(RS)-1-Phenylethyl b- -glucoside 11: HRFABMS: m/z 307.1158
D
[M+Na]+ (calcd for C14H20O6Na: 307.1158); 1H NMR (400 MHz,
CD3OD): d 1.47 (3H, d, J = 6.4 Hz, H-2), 3.41–3.76 (6H, m, H-200,
300, 400, 500, 600), 4.11 (0.5H, d, J = 8.0 Hz, H-100), 4.41 (0.5H, d,
J = 7.9 Hz, H-100), 4.82 (0.5H, q, J = 6.4 Hz, H-1), 4.95 (0.5H, q,
J = 6.4 Hz, H-1), 7.20 (1H, m, H-40), 7.29–7.41 (4H, m, H-20, 30, 50,
of these substrates, that is, (RS)-1-phenylalkyl b-D-glucosides 11
and 12, was confirmed to be 1:1 as judged by 1H NMR analysis
of H-100 anomeric proton signals [Fig. 3(A) for 11 and Fig. 5(A)
for 12].
13
60); C NMR (100 MHz, CD3OD): d 22.9, 24.3 (C-2), 69.9 (C-600),
70.1 (C-400), 75.2, 75.3 (C-200), 76.0, 78.0 (C-1), 78.5, 78.9 (C-300, C-
500), 102.0, 102.5 (C-100), 128.0, 128.5 (C-20, C-60), 128.9, 129.0 (C-
40), 130.0, 130.2 (C-30, C-50), 143.9, 145.8 (C-10).
The spectral data of b-
as follows.
2-Hydroxybenzyl b-
D
-glucoside substrates 1–6, 11, and 12 are
D
-glucoside 1: HRFABMS: m/z 309.1166
[M+Na]+ (calcd for C13H18O7Na: 309.1162); 1H NMR (400 MHz,
CD3OD): d 3.23–3.37 (4H, m, H-20, 30, 40, 50), 3.67 (1H, dd, J = 12.2,
5.1 Hz, H-6a0), 3.87 (1H, dd, J = 12.0, 1.6 Hz, H-6b0), 4.38 (1H, d,
J = 7.6 Hz, H-10), 4.70 (1H, d, J = 12.0 Hz, H-7a), 4.91 (1H, d,
J = 12.0 Hz, H-7b), 6.76 (1H, d, J = 7.8 Hz, H-3), 6.79 (1H, t,
J = 7.6 Hz, H-5), 7.08 (1H, t, J = 7.8 Hz, H-4), 7.30 (1H, d, J = 7.2 Hz,
(RS)-1-Phenylbutyl b- -glucoside 12: HRFABMS: m/z 335.1471
D
[M+Na]+ (calcd for C16H24O6Na: 335.1469); 1H NMR (400 MHz,
CD3OD): d 0.90 (3H, m, H-4), 1.28–1.41 (2H, m, H-3), 1.64–1.70
(2H, m, H-2), 3.09–3.51 (6H, m, H-200, 300, 400, 500, 600), 4.15 (0.5H, d,
J = 8.0 Hz, H-100), 4.49 (0.5H, d, J = 8.0 Hz, H-100), 4.85 (0.5H, t,
J = 7.6 Hz, H-1), 4.90 (0.5H, t, J = 7.6 Hz, H-1), 7.22 (1H, m, H-40),